
Cingulate
A clinical stage biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products.
Market cap
$17.3m
Enterprise value
$13m
Share price
$4.07 CING
Authorizing premium user...